Search Within

Kevin Joseph Curran

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (16)
  2. Journal Article (8)
  3. Research Letter (1)
Groups
  1. Advanced Practice Providers (25)
  2. Pediatrics, Department of (25)
  3. Stem Cell Transplantation and Cellular Therapy Service (25)
  4. Department of Medicine (24)
  5. GSK Faculty (24)
  6. Nursing (24)

More Groups

People
  1. Andromachi Scaradavou (13)
  2. Renier Brentjens (13)
  3. Elizabeth Halton (12)
  4. Isabelle Riviere (12)
  5. Jae Park (12)
  6. Nancy Kernan (12)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Blood (8)
  2. Bone Marrow Transplantation (5)
  3. Biology of Blood and Marrow Transplantation (3)
  4. Journal of Clinical Oncology (2)
  5. Haematologica (1)
  6. Journal of Pediatric Hematology/Oncology (1)

More Publications

Publishers
  1. American Society of Hematology (8)
  2. Nature Publishing Group (7)
  3. Elsevier Inc. (4)
  4. American Society of Clinical Oncology (2)
  5. American Association for the Advancement of Science (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Development and evaluation of a human single chain variable fragment (scFv) derived BCMA targeted CAR T Cell vector leads to a high objective response rate in patients with advanced MM
    Meeting Abstract

    Smith, E. L.; Mailankody, S.; Ghosh, A.; Masakayan, R.; Staehr, M.; Purdon, T. J.; Halton, E.; Diamonte, C.; Anant, P.; Bernal, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or - mismatched donors
    Journal Article

    Mussetti, A.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; Lehrman, R.; Ruggiero, J. M.; Curran, K.; Kobos, R.; O'Reilly, R.; Boulad, F.
    Pediatric Hematology and Oncology (2016)

    Fulltext@MSK | Save
  • Late effects in patients with Fanconi anemia following allogeneic hematopoietic stem cell transplantation from alternative donors
    Journal Article

    Praveen, A.; Friedman, D. N.; Sklar, C.; Oeffinger, K.; Castiel, M.; Kearney, J.; Singh, B.; Prockop, S. E.; Kernan, N. A.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T- cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic GVHD and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (< 21 years) with AML in CR1
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S. E.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Wolden, S.; Curran, K. J.; Hasan, A. N.; more...
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Implications of minimal residual disease negative complete remission (MRD-CR) and allogeneic stem cell transplant on safety and clinical outcome of CD19 targeted 19-28z CAR modified T cells in adult patients with relapsed, refractory B-cell ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Wang, Y.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
    Haematologica (2015)

    Fulltext@MSK | Save
  • Phase I clinical trial of autologous CD19-targeted 19-28z CAR T cells in adult patients with Relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Halton, E.; Quintanilla, H.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R. J.
    Molecular Therapy (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X. Y.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K. J.; Sauter, C. S.; Sadelain, M.; Brentjens, R. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • High disease-free survival (DFS) supports continued investigation of double-unit cord blood transplantation (DCBT) in children with high-risk acute leukemia especially in the setting of single units with low dose and/or a high degree of HLA-mismatch
    Meeting Abstract

    Scaradavou, A.; Lubin, M.; Hilden, P.; Boulad, F.; Curran, K. J.; Kobos, R.; Prockop, S. E.; O'Reilly, R. J.; Tonon, J. A.; Byam, C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save